It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The low biomass of respiratory samples makes it difficult to accurately characterise the microbial community composition. PCR conditions and contaminating microbial DNA can alter the biological profile. The objective of this study was to benchmark the currently available laboratory protocols to accurately analyse the microbial community of low biomass samples. To study the effect of PCR conditions on the microbial community profile, we amplified the 16S rRNA gene of respiratory samples using various bacterial loads and different number of PCR cycles. Libraries were purified by gel electrophoresis or AMPure XP and sequenced by V2 or V3 MiSeq reagent kits by Illumina sequencing. The positive control was diluted in different solvents. PCR conditions had no significant influence on the microbial community profile of low biomass samples. Purification methods and MiSeq reagent kits provided nearly similar microbiota profiles (paired Bray–Curtis dissimilarity median: 0.03 and 0.05, respectively). While profiles of positive controls were significantly influenced by the type of dilution solvent, the theoretical profile of the Zymo mock was most accurately analysed when the Zymo mock was diluted in elution buffer (difference compared to the theoretical Zymo mock: 21.6% for elution buffer, 29.2% for Milli-Q, and 79.6% for DNA/RNA shield). Microbiota profiles of DNA blanks formed a distinct cluster compared to low biomass samples, demonstrating that low biomass samples can accurately be distinguished from DNA blanks. In summary, to accurately characterise the microbial community composition we recommend 1. amplification of the obtained microbial DNA with 30 PCR cycles, 2. purifying amplicon pools by two consecutive AMPure XP steps and 3. sequence the pooled amplicons by V3 MiSeq reagent kit. The benchmarked standardized laboratory workflow presented here ensures comparability of results within and between low biomass microbiome studies.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Wilhelmina Children’s Hospital/University Medical Center Utrecht, Department of Paediatric Immunology and Infectious Diseases, Utrecht, The Netherlands (GRID:grid.417100.3) (ISNI:0000 0004 0620 3132); National Institute for Public Health and the Environment, Centre for Infectious Disease Control, Bilthoven, The Netherlands (GRID:grid.31147.30) (ISNI:0000 0001 2208 0118)
2 National Institute for Public Health and the Environment, Centre for Infectious Disease Control, Bilthoven, The Netherlands (GRID:grid.31147.30) (ISNI:0000 0001 2208 0118)
3 Wilhelmina Children’s Hospital/University Medical Center Utrecht, Department of Paediatric Immunology and Infectious Diseases, Utrecht, The Netherlands (GRID:grid.417100.3) (ISNI:0000 0004 0620 3132); National Institute for Public Health and the Environment, Centre for Infectious Disease Control, Bilthoven, The Netherlands (GRID:grid.31147.30) (ISNI:0000 0001 2208 0118); University of Edinburgh, University of Edinburgh Centre for Inflammation Research, Queen’s Medical Research Institute, Edinburgh, UK (GRID:grid.4305.2) (ISNI:0000 0004 1936 7988)